M
Maria Westerhoff
Researcher at University of Washington
Publications - 57
Citations - 719
Maria Westerhoff is an academic researcher from University of Washington. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 13, co-authored 41 publications receiving 575 citations. Previous affiliations of Maria Westerhoff include University of Michigan & University of Washington Medical Center.
Papers
More filters
Journal ArticleDOI
Erythropoietin protects epithelial cells from excessive autophagy and apoptosis in experimental neonatal necrotizing enterocolitis
Yueyue Yu,Sheng Ru Shiou,Yuee Guo,Lei Lu,Maria Westerhoff,Jun Sun,Elaine O. Petrof,Erika C. Claud +7 more
TL;DR: It was found that autophagy and apoptosis are both rapidly up regulated in NEC in vivo as indicated by increased expression of the autophile markers Beclin 1 and LC3II, and by evidence of apoptosis by TUNEL and cleaved caspase-3 staining.
Journal ArticleDOI
CD61, CD31, and CD34 improve diagnostic accuracy in gastric antral vascular ectasia and portal hypertensive gastropathy: An immunohistochemical and digital morphometric study.
TL;DR: In conclusion, CD61 reliably differentiates GAVE from PHG, and MVD analysis can also assist in their distinction.
Journal ArticleDOI
Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis
Christopher J. Damman,Mitchell J. Brittnacher,Maria Westerhoff,Hillary S. Hayden,Matthew C. Radey,Kyle R. Hager,Sara R. Marquis,Samuel I. Miller,Timothy L. Zisman +8 more
TL;DR: Following a single colonoscopic fecal transplant, a DSI of 40-50% is achieved in about two-thirds of recipients, and changes in transplant frequency or method might improve microbiota engraftment and efficacy.
Journal ArticleDOI
Effects of Dropping the Requirement for Goblet Cells From the Diagnosis of Barrett's Esophagus
TL;DR: Cutting the requirement for goblet cells in biopsy specimens of columnar mucosa within the esophageal biopsy samples would increase the diagnosis of Barrett's esophagus by 147% and cause many patients to be inaccurately labeled as BE.
Journal ArticleDOI
Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer
Zixu Yuan,Kelsey Baker,Mary W. Redman,Lei Wang,Scott V. Adams,Ming Yu,Brandon Dickinson,Karen W. Makar,Neli Ulrich,Jürgen Böhm,Michelle A. Wurscher,Maria Westerhoff,Steve Medwell,Ravi Moonka,Mika Sinanan,Alessandro Fichera,Kathy Vickers,William M. Grady,William M. Grady +18 more
TL;DR: Pre-operative plasma miR-29a, 200b, 203, and 31 are potential CRC prognosis biomarkers and dynamic postoperativeMiR-31, 141 and 16 levels are potential biomarkers for the early detection of recurrence during CRC surveillance.